I'm not sure how good it will be yet, but it's promising. Depends on pricing and availability and we don't know that yet.Hotlongs said:That's awesome news. One of the few positive headlines in a while. Thanks for sharing.
I'm not sure it will have any effect on grey. The way compounding companies previously worked was that you filled out a questionnaire, a licensed doctor approved it, and you got your GLP for a lot of cash per month. If they use the same model, they offer peptides and charge whatever the market will bear. This provides the illusion of approval via a medical process. What you pay for is the same thing as you get with grey, just in a more established or accepted process. I assume COAs will be included. I think this model will appeal more to the suburban Ken's and Karen's who have money to burn, and feel safer purchasing that way, as opposed to those of us that have done their homework on peptides and the grey market.Hotlongs said:Do you anticipate that this will put downward pressure on grey market pricing?
